Prostatic Acid Phosphatase

Prostatic acid phosphatase has been used as a tumor marker ever since the observation by Gutman in 1938¹ that elevated levels of this enzyme are found in patients with metastatic prostate cancer. PAP determination in conjunction with PSA measurements is useful in assessing the prognosis of prostate cancer.